XML 81 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity, Comprehensive Income and Share-Based Compensation (Tables)
9 Months Ended
Jul. 28, 2013
Equity [Abstract]  
Components of accumulated other comprehensive loss, after-tax basis
Components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
 
 
July 28,
2013
 
October 28,
2012
 
 
 
 
 
(In millions)
Unrealized gain on investments, net
$
19

 
$
16

Unrealized gain on derivative instruments qualifying as cash flow hedges
6

 
1

Pension liability
(92
)
 
(90
)
Cumulative translation adjustments
6

 
12

 
$
(61
)
 
$
(61
)
Summary of stock repurchases
The following table summarizes Applied’s stock repurchases for the periods indicated:
 
 
Three Months Ended
 
Nine Months Ended
 
July 28,
2013
 
July 29,
2012
 
July 28,
2013
 
July 29,
2012
 
 
 
 
 
 
 
 
 
(In millions, except per share amounts)
Shares of common stock repurchased
3

 
47

 
15

 
81

Cost of stock repurchased
$
50

 
$
500

 
$
198

 
$
900

Average price paid per share
$
15.33

 
$
10.71

 
$
13.18

 
$
11.09

Total share-based compensation and related tax benefits
Total share-based compensation and related tax benefits were as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
July 28,
2013
 
July 29,
2012
 
July 28,
2013
 
July 29,
2012
 
 
 
 
 
 
 
 
 
(In millions)
Share-based compensation
$
40

 
$
42

 
$
121

 
$
138

Tax benefit recognized
$
11

 
$
12

 
$
34

 
$
39

Effect of share-based compensation on the results of operations
The effect of share-based compensation on the results of operations for the three and nine months ended July 28, 2013 and July 29, 2012 was as follows:
 
 
Three Months Ended
 
Nine Months Ended
 
July 28,
2013
 
July 29,
2012
 
July 28,
2013
 
July 29,
2012
 
 
 
 
 
 
 
 
 
(In millions)
Cost of products sold
$
13

 
$
13

 
$
37

 
$
40

Research, development, and engineering
14

 
14

 
39

 
40

Marketing and selling
5

 
5

 
15

 
17

General and administrative
8

 
10

 
25

 
41

Restructuring charge

 

 
5

 

Total
$
40

 
$
42

 
$
121

 
$
138

Stock option activity
Stock option activity for the nine months ended July 28, 2013 was as follows:
 
 
Shares
 
Weighted
Average
Exercise
Price
 
 
 
 
 
(In millions, except per share amounts)
Outstanding at October 28, 2012
21

 
$
10.53

Granted

 
$

Exercised
(10
)
 
$
8.00

Canceled and forfeited
(5
)
 
$
17.63

Outstanding at July 28, 2013
6

 
$
8.69

Exercisable at July 28, 2013
6

 
$
8.77

Performance-based awards
A summary of the performance-based awards approved by the Committee is presented below:
 
 
Number of Performance-Based Awards Granted
 
Percent of Performance-Based Awards Earned as of July 28, 2013*
Fiscal Year Granted
 
Performance Shares/Performance Units
 
Shares of
Restricted Stock
 
 
 
(in millions)
 
 
2013
 
3

 

 
0%
2012
 
3

 
1

 
14%
2011
 
2

 
0.1

 
100%
2010
 
2

 
0.1

 
82%
___________________
* subject to additional time-based vesting requirements
Restricted stock units and restricted stock activity
A summary of the changes in restricted stock units, restricted stock, performance shares and performance units outstanding under Applied’s equity compensation plans during the nine months ended July 28, 2013 is presented below:
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Contractual Term
 
 
 
 
 
 
 
(In millions, except per share amounts)
 
 
Non-vested restricted stock units, restricted stock, performance shares and performance units at October 28, 2012
36

 
$
11.53

 
2.6 years
Granted
18

 
$
10.36

 
 
Vested
(11
)
 
$
11.46

 
 
Canceled
(5
)
 
$
11.33

 
 
Non-vested restricted stock units, restricted stock, performance shares and performance units at July 28, 2013
38

 
$
11.03

 
2.7 years
Underlying assumptions used in ESPP valuation model
Underlying assumptions used in the model are outlined in the following table:
 
Nine Months Ended
 
July 28, 2013
 
July 29, 2012
ESPP:
 
 
 
Dividend yield
2.94%
 
2.94%
Expected volatility
24.3%
 
33.0%
Risk-free interest rate
0.12%
 
0.12%
Expected life (in years)
0.5
 
0.5